Galderma Group AG
Galderma Group AG, a leading global dermatology company, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1981, Galderma has established itself as a pioneer in the dermatological field, focusing on innovative solutions for skin health. The company is renowned for its core products, including aesthetic injectables, prescription dermatology treatments, and skincare solutions, which are distinguished by their scientific rigor and commitment to safety. Galderma's flagship brands, such as Restylane and Differin, have garnered significant market recognition, positioning the company as a trusted name in both medical and aesthetic dermatology. With a strong emphasis on research and development, Galderma continues to achieve notable milestones, solidifying its status as a key player in the global dermatology market.
DitchCarbon Score
How does Galderma Group AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Galderma Group AG's score of 34 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Galderma Group AG's reported carbon emissions
In 2023, Galderma Group AG reported total carbon emissions of approximately 332,100,000 kg CO2e, with emissions distributed across various scopes: 7,600,000 kg CO2e for Scope 1, 5,500,000 kg CO2e for Scope 2, and the majority, 332,100,000 kg CO2e, attributed to Scope 3 emissions. The total emissions from Scope 1 and 2 combined were about 8,100,000 kg CO2e. In 2022, the company reported a total of approximately 7,400,000 kg CO2e for Scope 1 and 2 emissions, with Scope 2 emissions alone at about 5,600,000 kg CO2e. This indicates a slight increase in emissions from 2022 to 2023. Galderma has not disclosed any specific reduction targets or initiatives, nor does it appear to have cascaded data from a parent company. The absence of climate pledges or SBTi targets suggests that the company may still be in the early stages of formalising its climate commitments. Overall, while Galderma Group AG has provided emissions data, further details on reduction strategies and long-term climate goals are currently lacking.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | 0,000,000 |
| Scope 2 | 5,600,000 | 0,000,000 |
| Scope 3 | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Galderma Group AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
